DK0533862T3 - Rekombinante human faktor VIII-derivater - Google Patents

Rekombinante human faktor VIII-derivater

Info

Publication number
DK0533862T3
DK0533862T3 DK92905708T DK92905708T DK0533862T3 DK 0533862 T3 DK0533862 T3 DK 0533862T3 DK 92905708 T DK92905708 T DK 92905708T DK 92905708 T DK92905708 T DK 92905708T DK 0533862 T3 DK0533862 T3 DK 0533862T3
Authority
DK
Denmark
Prior art keywords
recombinant human
factor viii
human factor
viii derivatives
derivatives
Prior art date
Application number
DK92905708T
Other languages
Danish (da)
English (en)
Inventor
Eva Maria Hellstrim
Peter Lind
Helena Inga Sandberg
Jack Spira
Annelie B Almstedt
Catherine Ljung
Mona Sydow-Baeckman
Helena Wiman
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of DK0533862T3 publication Critical patent/DK0533862T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92905708T 1991-03-15 1992-03-11 Rekombinante human faktor VIII-derivater DK0533862T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9100799A SE468050C (sv) 1991-03-15 1991-03-15 Rekombinant derivat av human faktor VIII
PCT/SE1992/000150 WO1992016557A1 (en) 1991-03-15 1992-03-11 Recombinant human factor viii derivatives

Publications (1)

Publication Number Publication Date
DK0533862T3 true DK0533862T3 (da) 2000-01-17

Family

ID=20382191

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92905708T DK0533862T3 (da) 1991-03-15 1992-03-11 Rekombinante human faktor VIII-derivater

Country Status (17)

Country Link
EP (1) EP0533862B1 (sv)
JP (1) JP2655752B2 (sv)
AR (1) AR247590A1 (sv)
AT (1) ATE186055T1 (sv)
AU (1) AU650730B2 (sv)
CA (1) CA2081659C (sv)
DE (1) DE69230206T2 (sv)
DK (1) DK0533862T3 (sv)
ES (1) ES2137182T3 (sv)
FI (1) FI107539B (sv)
GR (1) GR3032468T3 (sv)
IE (1) IE920814A1 (sv)
NO (1) NO308174B1 (sv)
PT (1) PT100245B (sv)
SE (1) SE468050C (sv)
WO (1) WO1992016557A1 (sv)
ZA (1) ZA921882B (sv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595886A (en) * 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
US6060447A (en) * 1987-05-19 2000-05-09 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US5663060A (en) * 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5744446A (en) * 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5364771A (en) * 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
ATE174628T1 (de) 1992-07-31 1999-01-15 Medeva Holdings Bv Expression rekombinanter fusionsproteine in attenuierten bakterien
SE9300509D0 (sv) * 1993-02-16 1993-02-16 Kabi Pharmacia Ab Peg treatment
SE504074C2 (sv) * 1993-07-05 1996-11-04 Pharmacia Ab Proteinberedning för subkutan, intramuskulär eller intradermal administrering
GB9401787D0 (en) * 1994-01-31 1994-03-23 Medeva Holdings Bv Vaccine compositions
SE9303601D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Improved cell cultivation method and medium
SE9403915D0 (sv) * 1994-11-14 1994-11-14 Annelie Almstedt Process A
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII
US7112438B2 (en) 1999-01-04 2006-09-26 Dyax Corp. Binding molecules for human factor VIII and factor VIII-like proteins
EP1048726B1 (en) * 1999-04-27 2006-07-26 Négrier, Claude Modified factor VIII cDNA
EP1038959A1 (en) 1999-03-17 2000-09-27 Aventis Behring Gesellschaft mit beschränkter Haftung Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
SE9901379D0 (sv) 1999-04-19 1999-04-19 Pharmacia & Upjohn Ab Receptor structures
EP1233064A1 (en) 2001-02-09 2002-08-21 Aventis Behring Gesellschaft mit beschränkter Haftung Modified factor VIII cDNA and its use for the production of factor VIII
EP1283263A1 (en) * 2001-08-08 2003-02-12 Aventis Behring GmbH Modified cDNA for high expression levels of factor VIII and its derivatives
EP1284290A1 (en) * 2001-08-08 2003-02-19 Aventis Behring GmbH Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA
JP5054975B2 (ja) 2003-09-30 2012-10-24 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア アデノ随伴ウイルス（ａａｖ）の同源系統群、配列、それらを含有するベクターおよびそれらの用途
JP5702519B2 (ja) 2005-04-07 2015-04-15 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Ａａｖベクターの機能を上げる方法
AU2006233638A1 (en) * 2005-04-14 2006-10-19 Csl Behring Gmbh Modified coagulation Factor VIII with enhanced stability and its derivates
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
US20130023033A1 (en) 2010-03-29 2013-01-24 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1
ES2724800T3 (es) 2011-02-17 2019-09-16 Univ Pennsylvania Composiciones y métodos para alterar la especificidad de tejido y mejorar la transferencia génica mediada por AAV9
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
CN105017410B (zh) * 2014-04-18 2018-06-08 北京诺思兰德生物技术股份有限公司 一种b区部分缺失型重组人凝血因子ⅷ
ES2763551T3 (es) 2015-04-16 2020-05-29 Univ Emory Promotores y vectores recombinantes para la expresión de proteínas en el hígado y uso de los mismos
JP7382138B2 (ja) * 2016-10-03 2023-11-16 第一三共株式会社 Ｈｓｐａ５遺伝子のプロモーター
US20240043494A1 (en) 2020-08-07 2024-02-08 Amicus Therapeutics, Inc. Vesicle Targeting Proteins And Uses Of Same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers
JPS62181786A (ja) * 1985-08-12 1987-08-10 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド 融合蛋白質の製造法
US4935233A (en) * 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
NO872932L (no) * 1986-07-18 1988-01-19 Gist Brocades Nv Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika.
NZ219516A (en) * 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
DE3720246A1 (de) * 1987-06-19 1988-12-29 Behringwerke Ag Faktor viii:c-aehnliches molekuel mit koagulationsaktivitaet
EP0500734B1 (en) * 1989-11-17 1998-02-11 Novo Nordisk A/S Protein complexes having factor viii:c activity and production thereof
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
CA2078721A1 (en) * 1991-09-24 1993-03-25 Hiroshi Yonemura Process for preparing human coagulation factor viii protein complex

Also Published As

Publication number Publication date
NO924395D0 (no) 1992-11-13
AU1351392A (en) 1992-10-21
NO308174B1 (no) 2000-08-07
DE69230206D1 (de) 1999-12-02
DE69230206T2 (de) 2000-05-18
SE468050C (sv) 1998-04-27
NO924395L (no) 1993-01-13
SE468050B (sv) 1992-10-26
PT100245A (pt) 1993-07-30
CA2081659A1 (en) 1992-09-16
FI925131A0 (fi) 1992-11-11
SE9100799L (sv) 1992-09-16
WO1992016557A1 (en) 1992-10-01
ZA921882B (en) 1992-11-25
PT100245B (pt) 1999-08-31
JPH05507420A (ja) 1993-10-28
FI107539B (sv) 2001-08-31
AR247590A1 (es) 1995-01-31
AU650730B2 (en) 1994-06-30
ATE186055T1 (de) 1999-11-15
EP0533862A1 (en) 1993-03-31
CA2081659C (en) 2002-06-25
IE920814A1 (en) 1992-09-23
GR3032468T3 (en) 2000-05-31
SE9100799D0 (sv) 1991-03-15
FI925131A (fi) 1992-11-11
JP2655752B2 (ja) 1997-09-24
EP0533862B1 (en) 1999-10-27
ES2137182T3 (es) 1999-12-16

Similar Documents

Publication Publication Date Title
DK0533862T3 (da) Rekombinante human faktor VIII-derivater
ATE190066T1 (de) Neuartige peptidderivate
FI941398A0 (sv) Modifierade peptidderivat
DE69229205T2 (de) Chirurgischer Retraktor
FI934541A (fi) Antibakteriellt milt flytande hudrengoeringsmedel
FI921740A (fi) Hybrid polypeptid
NO923127L (no) Farmasoeytisk kombinasjonsformulering
DE69213065T2 (de) ISDN-Analog-Zwischeneinheit
DK162890D0 (da) Polypeptid
MA22717A1 (fr) Peptides hemoregulateurs
FI90727C (sv) Munstycke
DK56591D0 (da) Toerringsfremgangsmaade
FI920701A (fi) Anordning foer terapeutisk tryckbehandling
KR920019179U (ko) 지압벼개
DK111891D0 (da) Polypeptid
IT226127Z2 (it) Specchietto particolarmente per odontoiatrica
KR920017842U (ko) 진주패의 평판상세단기
KR930006241U (ko) 환자용 벼개
DK106390D0 (da) Polypeptid
DK236190D0 (da) Polypeptid
DK185590D0 (da) Polypeptid
KR920017797U (ko) 드로우어웨이팁
BR7100795U (pt) Protetor facial
BR7100575U (pt) Bone dobravel
ATA32191A (de) Abgabeverschluss